Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Drug delivery firm Generex Biotechnology has announced the US launch of its innovative new over-the-counter diabetes management product, Glucose RapidSpray.
Subscribe to our email newsletter
Glucose RapidSpray delivers a fat-free, low-calorie glucose formulation that was developed using the company’s proprietary buccal drug delivery technologies. The product delivers glucose directly into the mouth where it is rapidly absorbed.
Among its benefits, Generex claims Glucose RapidSpray is simple to carry and use, with no large tablets to chew or messy gels to swallow.
“Using our patented technologies – RapidMist – we’ve developed a product that will deliver glucose to anyone who needs a fast and efficient means for receiving glucose,” said Anna Gluskin, president & CEO of Generex. “We expect that Glucose RapidSpray will appeal to people battling the symptoms of low blood sugar who now use other over-the-counter glucose products but want a faster-acting product. We expect to position Glucose RapidSpray as a companion product to Generex Oral-lyn, our proprietary oral insulin spray product, in the diabetes management field.”
Generex is in the process of engaging distributors to place the product in independent retail pharmacies throughout the US. Glucose RapidSpray is expected to be in US stores by October 2006.